NA Proactive news snapshot: Golden Arrow Resources, Phunware, 1933 Industries, Matinas BioPharm UPDATE …

Golden Arrow Resources Corporation (CVE:GRG) (OTCMKTS:GARWF) said it has retained Michael Baybak and Company to provide financial communication, media relations and market development consulting services. In a statement, the Vancouver explorer said Baybak has been engaged for a term of six months at a monthly fee of US$8,000 for the first two months and US$6,000 for the following months. In addition, the company will grant 100,000 stock options to purchase common shares of the company at an exercise price to be determined at the time of grant. Golden Arrow is actively exploring a portfolio that includes advanced projects in Chile, a district-scale frontier opportunity in Paraguay, and more than 185,000 hectares of properties in Argentina.

Phunware Inc (NASDAQ:PHUN) is boosting its software development kits with new functionalities for its location-based services. The Austin, Texas-based company told shareholders on Thursday that it was adding landmark routing capabilities to its location-based services platform to allow the applications to display navigation instructions in a user-friendly way. As part of the new functionality, certain points of interest can be marked as landmarks to enable more visual directions, such as instructing users to “turn left at the front desk” rather than “20 feet.”

1933 Industries Inc (CSE:TGIF) (OTCMKTS:TGIFF) announced Thursday that it has signed a second licensing agreement with OG DNA Genetics, a globally recognized leading cannabis brand. The agreement will grant 1933 Industries the license to the DNA brand for the production and sale of hemp-derived CBD products – signaling DNA’s first entry into the cannabidiol market. DNA will leverage 1933’s vast distribution network of over 800 retail outlets throughout the US. In 2018, the Farm Bill was passed through legislation federally legalizing the cultivation of hemp and permitting the sale of hemp-derived CBD products. This gives DNA the ability to expand its reach into the rapidly developing CBD market and provide the highest-quality products to all 50 states and globally.

Matinas BioPharma Holdings Inc (NYSEAMERICAN:MTNB) said Thursday that it has started a feasibility appraisal with Roche’s biotechnology subsidiary Genentech for developing oral formulations using the company’s lipid nano-crystal (LNC) platform delivery technology, which allows the development of a range of difficult-to-deliver molecules. Bedminster, New Jersey-based Matinas is working on the advancement of its proprietary LNC platform technology for the safe delivery of therapies previously limited by toxicity or bioavailability issues. The technology is aimed at solving complex challenges relating to the safe and effective delivery of potent medicines.

Valens Groworks Corp (CVE:VGW) (OTCMKTS:VGWCF) said Thursday that it has stuck an amended manufacturing and sales licence agreement with SōRSE Technology Corporation, which granted it an exclusive licence for Canada, Europe, Australia and Mexico to use the proprietary SōRSE emulsion technology to produce, sell and distribute cannabis-infused products. In a statement, the British Columbia-based vertically integrated provider of extraction products and services said that with the “expanded agreement” in place, the company has extended the opportunity for its existing customers to key international markets.

American Manganese Inc (CVE:AMY) (OTCMKTS:AMYZF) updated Thursday on its partnership with the US Department of Energy (DOE), which aims to advance the recovery of lithium-ion battery materials from electric vehicles (EVs) and other products. Its Kemetco Research contractor has begun testing cathode materials from disassembled electric vehicle battery packs supplied by a Critical Material Institute (CMI) team member. It is all part of a US government project, which was announced in March this year, which is focused on creating a multi-year project that focuses on creating a circular economy for lithium-ion batteries.

Atlas Engineered Products Ltd (CVE:AEP) (OTCMKTS:APEUF) on Thursday provided an update on the significant contracts being awarded at its three facilities in western Canada. The biggest win for the Nanaimo, British Columbia-based company is four multi-family development projects totalling over $2.3 million of combined engineered wood product and truss packages.

CB2 Insights Inc (CSE:CBII) (OTCMKTS:CBIIF) is ready to set Sail with its core technology platform aimed at connecting unequal data systems. The company’s core technology, Sail, brings together multiple data references from production, retail, medical and product information into a single platform to help licensed producers or operators to improve efficiencies in data handling. The data analytics company said that Sail is the cannabis sector’s first cannabinoid-focused healthcare data aggregation tool.

RNC Minerals (TSE:RNX) told investors it was “very well” positioned to meet or beat its previously announced second-half guidance for 2019 of between 42,000 and 49,000 ounces, as the company reported strong output for November. The mining group is focused on integrating its Beta Hunt gold mine in Western Australia with the recently acquired Higginsville Gold Operation (HGO), which includes a processing mill, in Western Australia. Consolidated gold production for the month came in at 9,485 ounces.

Dunnedin Ventures Inc (CVE:DVI) is expecting assays in January next year after it completed the first drill program at the MPD copper-porphyry project in British Columbia, it told investors on Thursday. The work was completed on time and below budget and exceeded the target of 1,500 metres by completing 1,766 metres in three separate holes, the Vancouver-based firm told investors. All holes hit prospective sulphide-bearing, altered porphyritic host rocks, the firm added. Also in today’s statement, the company revealed it had closed a private placement of non-flow-through (NFT) units and flow-through (FT) units for gross proceeds of C$605,850 to be used for exploration in British Columbia and Arizona, and for general corporate purposes.

Ximen Mining Corp (CVE:XIM) (OTCMKTS:XXMMF) is set to raise C$350,000 to be spent on exploration at its British Columbia assets. The financing is a private placing of 897,436 flow-through shares at a C$0.39 a throw for gross proceeds of $350,000.

CytoDyn Inc (OTCMKTS:CYDY) said that CEO  Nader Pourhassan will host an investment community conference call to update on the biotech firm, which is developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications. It will take place on December 17 at 4pm EST. Dial In: 877-407-2986 U.S. and Canada 201-378-4916 International. A live audio webcast may also be accessed via CytoDyn’s corporate website, it added.

Capstone Turbine Corporation (NASDAQ:CPST), the maker of clean-energy microturbines, will be participating in the alphaDIRECT Virtual Conference Series on December 17 at 12:00 pm ET. Chief Revenue Officer Jim Crouse will present an overview of Capstone and the renewable future followed by a short Q&A session. The presentation will be webcast live and available for replay by visiting the investor relations section of the company’s website at www.capstoneturbine.com. “We are going to see more and more governmental policy and regulations drive towards renewable and decarbonization of all energy consumption,” Crouse said.

Biocept Inc (NASDAQ:BIOC) announced the closing of its $10 million underwritten public offering. The San Diego-based liquid biopsy firm closed a previously announced public offering of 24,600,000 shares of its common stock paired with warrants to purchase up to the same number of shares. The $10 million gross proceeds will be used to support ongoing operations and expansion of its business. Each common share was sold together with a warrant to purchase one share of common stock at a combined price of $0.405 per share and warrant. Biocept said it has granted Maxim Group a 45-day option to purchase up to an additional 3.69 million shares of common stock.

EnWave Corporation (CVE:ENW) has granted an aggregate of 685,000 incentive stock options to one director and certain employees. The incentive stock options are exercisable at a price of C$1.74 per share, the last closing price per share on the company’s common shares on the TSX Venture Exchange on the date of the grant. The stock options are exercisable for a term of five years expiring on December 11, 2024. EnWave also has granted 25,000 incentive stock options to Adelaide Capital Markets, an investor relations consultant providing services in the North American capital markets. The stock options granted to the consultant are exercisable at a price of C$1.74 per share and vest quarterly over the next 12 months. EnWave’s stock recently traded around C$1.72 a share in Toronto.

mCloud Technologies Corp (CVE:MCLD) told shareholders Thursday it had completed a share rollback that sees the company consolidate outstanding shares on a 1:10 basis. The move is part of the firm’s previously stated plan to elevate to the tech-centric Nasdaq exchange in the US and upgrade to the Toronto Stock Exchange in Canada. After the consolidation, mCloud will have roughly 15.7 million common shares issued and outstanding.  As a result of the consolidation, the principal amount of the convertible debentures is convertible into units of the company at the conversion price of C$5 per unit, while the principal amount of the company’s listed debentures outstanding is currently convertible into units of the company at the conversion price of C$0.50 per unit.

Fidelity Minerals Corp (CVE:FMN) confirmed Thursday that the mineral exploration company had consolidated its capital as part of a share rollback program. The firm recently announced plans to consolidate just over 132 million shares on a 5:1 basis, reducing the number of issued shares to nearly 26,500 post-consolidation. Fidelity’s consolidated shares will commence trading on the TSX Venture Exchange on December 13.

Story by ProactiveInvestors